| Product Name | Erianin |
|---|---|
| CAS | 95041-90-0 |
| Formula | C18H2205 |
| MW | 318.36 |
| Appearance | 白色粉末 |
| Boiling point | 439.1±40.0 °C | Condition: Press: 760 Torr |
| PKa | 9.99±0.10 | Condition: Most Acidic Temp: 25 °C |
| Product Name | Erianin |
|---|---|
| CAS | 95041-90-0 |
| Formula | C18H2205 |
| MW | 318.36 |
| Appearance | 白色粉末 |
| Boiling point | 439.1±40.0 °C | Condition: Press: 760 Torr |
| PKa | 9.99±0.10 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000378
中文名稱：毛蘭素
中文別名：2-甲氧基-5-(3,4,5-三甲氧基苯乙基)苯酚；2-甲氧基-5-2-(3,4,5-三甲氧基苯基)乙基苯酚；2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯酚
英文名稱：Erianin
英文別名：2-Methoxy-5-[2-(3,4,5-trimethoxyphenyl)ethyl]phenol;Erianin;NSC 613744;
分子式：C18H2205
分子量：318.36
CAS號：95041-90-0
純度：HPLC≥98%
沸點：439.1±40.0 °C | Condition: Press: 760 Torr
密度：1.147±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：9.99±0.10 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| Simultaneous Quantification of 11 Phenolic Compounds and Consistency Evaluation in Four Dendrobium Species Used as Ingredients of the Traditional Chinese Medicine Shihu | ||
| Source:SCI：Frontiers in Nutrition | Author:An-Ling Zhu | Notes：影響因子：6.576 |
| Reference description | ||
The double-distilled water was prepared in the laboratory by using a Milli-Q system (Millipore, Bedford, MA, USA). Schaftoside (1), isoschaftoside (2), 2,4,7-trihydroxy-9,10-dihydrophenanthrene (3), dihydroresveratrol (4), coelonin (5), nudol (6), gigantol (7), 4-methoxy-2,5- phenanthrenediol (8), 3-hydroxy-3,4,5-trimethoxybibenzy (9), erianin (10), and tristin (11) were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Sichuan province, Chengdu, China). The purity of all the reference standards was above 98%. The structures of these standards are shown in Figure 1. | ||
